The conference will feature 60 biotechnology experts from over 30 countries covering current developments and issues addressing the commercialization of biotechnology in times of challenges and change.
The benefits of the conference include:
- 3 tracks, 6 plenary sessions and more than 60 presentations focusing on challenges and opportunities in the commercialization of biotechnology
- Exploring strategies in a changing landscape for agriculture, healthcare and industrial biotechnology
- Discovering funding opportunities
- Strengthening scientific collaborations
- Improving human capital and professional development
- Enhancing effective partnerships
- Expanding networking with biotechnology business leaders, scientists, investors and regulators
|